1. JCR-IPOP: Do We Need More or Less Physiology or Imaging?
Room A : 09:00~10:30
Chair
Myeong-Ki Hong, Seung-Ho Hur, Jung Ho Heo
Panel
Seokhun Yang, Xinyang Hu, Min Gyu Kang
Speaker
| 09:00-09:20 |
FFR-Guidance for Complete Nonculprit Revascularization
Joo Myung Lee
(Samsung Medical Center, Korea(Rep.of))
|
| 09:20-09:40 |
QFR is enough or not?
You-Jeong Ki
(Uijeongbu Eulji Medical Center, Korea(Rep.of))
|
| 09:45-10:00 |
OCT in complex PCI
Sung-Jin Hong
(Severance Cardiovascular Hospital, Korea(Rep.of))
|
2. JCR-PTRG Joint Symposium: Recent Evidence Review of Antithrombotic Therapy
Room A : 11:00~12:20
Chair
Moo Hyun Kim, Jung Rae Cho, Mamas Andreas Mamas
Panel
Jung Won Suh, Jae Hyoung Park, Dae Young Cheon, Janghoon Lee, Jung-Joon Cha
Speaker
| 11:00-11:15 |
Role of Ticargrelor Montherapy in ACS Patients After PCI: Updated review from the T-PASS and ULTIMATE-DAPT trials
Yong-Joon Lee
(Severance Cardiovascular Hospital, Korea(Rep.of))
|
| 11:15-11:30 |
Which is the Best Strategy in Patients with High Bleeding and Ischemic Risk After PCI: Updated review from the OPT-BIRISK Trial
Doyeon Hwang
(Seoul National University Hospital, Korea(Rep.of))
|
| 11:30-11:45 |
DOAC has a role of stroke prevention in patients without AF, but with device-detected atrial high-rate episodes?: Updated review from the NOAH-AFNET 6 Trial
Hyo-Jeong Ahn
(Seoul National University Hospital, Korea(Rep.of))
|
| 11:45-12:00 |
Impact of TEG-MA & VerifyNow-PRU in Patients Who Underwent PCI
Osung Kwon
(Eunpyeong Saint Mary Hospital, Korea(Rep.of))
|
35. Sponsored Scientific Luncheon: The Recent Trend of Comorbidity Management in Hypertensive Patients with Dyslipidemia (Sponsored by Hanmi Pharmaceutical Co., Ltd.)
Room A : 12:30~13:30
Chair
Kook-Jin Chun, Seung-Ho Hur
Panel
Yonghwan Lee, Jae Sik Jang, Young-Rak Cho, Min Gyu Kang, Jeong Cheon Choe, Jin Hee Kim
Speaker
| 12:30-13:00 |
Optimal comorbidity management for CV protection in hypertensive patients with dyslipidemia
Jung Ho Heo
(Kosin University Gospel Hospital, Korea(Rep.of))
|
3. Update of ACS/PCI
Room A : 13:30~14:50
Chair
Moo Hyun Kim, Robert Patrick Giugliano, Tae Hoon Ahn
Panel
Hoyoun Won, Yonghwan Lee, Jae Sik Jang, Jung Ho Heo, Woohyung Bae, Jae Hyoung Park, Shun Kohsaka, Jongshin Woo
Speaker
| 13:30-13:45 |
Latest ACS / PCI Guidelines
Robert Patrick Giugliano
(Brigham and Women's Hospital, USA | Harvard Medical School, USA)
|
| 13:45-14:00 |
What is the optimal glycemic target in ACS patients?
Yumi Kang
(Brigham and Women's Hospital, Harvard Medical School, USA)
|
| 14:00-14:15 |
Contemporary approach to left main revascularization
Brian A. Bergmark
(Brigham and Women's Hospital, Heart and Vascular Center, USA)
|
| 14:15-14:30 |
Balancing high bleeding / high ischemic risk
Mamas Andreas Mamas
(Keele University, United Kingdom)
|
4. JCR-CCT: All About Complex PCI Complications: How to Solve Them? (Case-Based Learning)
Room A : 15:20~16:50
Chair
Moo Hyun Kim, Kook-Jin Chun, Satoru Otsuji
Panel
Bong-Ki Lee, Jin Bae Lee, Kenya Nasu
Speaker
| 15:20-15:35 |
Case 1
Janghoon Lee
(Kyungpook National University Hospital, Korea(Rep.of))
|
| 15:35-15:50 |
Case 2
Kenya Nasu
(Mie Heart Center, Japan)
|
| 15:50-16:05 |
Case 3
Jung Ho Heo
(Kosin University Gospel Hospital, Korea(Rep.of))
|
| 16:05-16:20 |
Case 4
Astunori Okamura
(Sakurabashi Watanabe Advanced Healthcare Hospital, Japan)
|
34. The Symposium of Atherosclerosis and Cardiovascular Intervention Research Institute
Room A : 17:10~18:30
Chair
Shung chull Chae, Kee-Sik Kim, Jun-Jie Zhang
Panel
Woohyung Bae, Xinyang Hu, Mark Chan Yan Yee, Hoyoun Won, Dong Won Lee
Speaker
| 17:10-17:30 |
Optimal antiplatelet therapy for secondary or primary prevention of cardiovascular disease
Hyo-Soo Kim
(Seoul National University Hospital, Korea(Rep.of))
|
| 17:30-17:50 |
CADENCE and ASPIRE – bringing together cardiovascular researchers within Singapore and regionally
Derek Hausenloy
(Duke-National University of Singapore Medical School, Singapore)
|
| 17:50-18:10 |
40th Anniversary of the TIMI trials
Robert Patrick Giugliano
(Brigham and Women's Hospital, USA | Harvard Medical School, USA)
|